JaLCDOI 10.18926/AMO/67868
FullText URL 78_6_429.pdf
Author Kubota, Risa| Bekku, Kensuke| Katayama, Satoshi| Iwata, Takehiro| Nishimura, Shingo| Edamura, Kohei| Kobayashi, Tomoko| Kobayashi, Yasuyuki| Araki, Motoo|
Abstract Although partial nephrectomy (PN) is preferred over radical nephrectomy (RN) for preserving renal function in patients with cT1 renal cancer, its impact on cardiovascular events (CVe) remains controversial. This study aimed to compare PN and RN in regard to the occurrence of CVe, including cerebrovascular events and exacerbation of hypertension (HT). We retrospectively analyzed 418 consecutive patients who underwent PN or RN for cT1 renal cancer. Propensity score-matching analysis was used to adjust for imbalances between patients who underwent PN and RN, leaving 102 patients in each group. The 5-year probability of cumulative CVe incidence was 6% in the PN group and 12% in the RN group (p=0.03), with a median follow-up of 73.5 months. The statistical significance was retained after propensity score matching for patients without preoperative proteinuria (p=0.03). For all CVe including cerebrovascular events and exacerbation of HT analyzed, PN provided a lower probability of occurrence than RN in patients with small renal cancers.
Keywords chronic kidney disease hypertension nephrectomy proteinuria
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-12
Volume volume78
Issue issue6
Publisher Okayama University Medical School
Start Page 429
End Page 437
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
FullText URL fulltext.pdf
Author Bekku, Kensuke| Kawada, Tatsushi| Sekito, Takanori| Yoshinaga, Kasumi| Maruyama, Yuki| Yamanoi, Tomoaki| Tominaga, Yusuke| Sadahira, Takuya| Katayama, Satoshi| Iwata, Takehiro| Nishimura, Shingo| Edamura, Kohei| Kobayashi, Tomoko| Kobayashi, Yasuyuki| Araki, Motoo| Niibe, Yuzuru|
Keywords renal cell carcinoma oligo-metastasis oligo-recurrence oligo-progression metastasectomy stereotactic body radiation therapy
Published Date 2023-12-17
Publication Title Cancers
Volume volume15
Issue issue24
Publisher MDPI
Start Page 5873
ISSN 2072-6694
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 by the authors.
File Version publisher
PubMed ID 38136417
DOI 10.3390/cancers15245873
Web of Science KeyUT 001131355800001
Related Url isVersionOf https://doi.org/10.3390/cancers15245873
FullText URL fulltext.pdf
Author Sakaeda, Kazuma| Sadahira, Takuya| Maruyama, Yuki| Iwata, Takehiro| Watanabe, Masami| Wada, Koichiro| Araki, Motoo|
Keywords antimicrobial resistance Escherichia coli urinary tract infections flomoxef ST131
Published Date 2023-03-06
Publication Title Antibiotics
Volume volume12
Issue issue3
Publisher MDPI
Start Page 522
ISSN 2079-6382
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 by the authors.
File Version publisher
PubMed ID 36978389
DOI 10.3390/antibiotics12030522
Web of Science KeyUT 000952995400001
Related Url isVersionOf https://doi.org/10.3390/antibiotics12030522
FullText URL fulltext20230317-1.pdf
Author Tominaga, Yusuke| Fujii, Masanori| Sadahira, Takuya| Katayama, Satoshi| Iwata, Takehiro| Nishimura, Shingo| Bekku, Kensuke| Edamura, Kohei| Kobayashi, Tomoko| Kobayashi, Yasuyuki| Kiura, Katsuyuki| Maeda, Yoshinobu| Wada, Koichiro| Araki, Motoo|
Keywords bladder tuberculosis bacillus Calmette-Guerin bladder cancer ureteral stricture voiding dysfunction
Published Date 2022-12-20
Publication Title Molecular and Clinical Oncology
Volume volume18
Issue issue2
Publisher Spandidos Publications
Start Page 7
ISSN 2049-9450
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © Tominaga et al.
File Version publisher
PubMed ID 36761388
DOI 10.3892/mco.2022.2603
Web of Science KeyUT 000928771000001
Related Url isVersionOf https://doi.org/10.3892/mco.2022.2603
JaLCDOI 10.18926/AMO/62820
FullText URL 75_6_763.pdf
Author Iwata, Takehiro| Sadahira, Takuya| Maruyama, Yuki| Sekito, Takanori| Yoshinaga, Kasumi| Watari, Shogo| Nagao, Kentaro| Kawada, Tatsushi| Tominaga, Yusuke| Nishimura, Shingo| Takamoto, Atsushi| Sako, Tomoko| Edamura, Kohei| Kobayashi, Yasuyuki| Araki, Motoo| Ishii, Ayano| Watanabe, Masami| Watanabe, Toyohiko| Nasu, Yasutomo| Wada, Koichiro|
Abstract The aim of this ongoing trial is to evaluate the clinical efficacy and safety of sitafloxacin (STFX) 200 mg once daily (QD) for 7 days in patients with refractory genitourinary tract infections, which include recurrent or complicated cystitis, complicated pyelonephritis, bacterial prostatitis, and epididymitis. The primary endpoint is the microbiological efficacy at 5-9 days after the last administration of STFX. Recruitment began in February 2021, and the target total sample size is 92 participants.
Keywords genitourinary tract infections fluoroquinolone resistance extended-spectrum beta-lactamase
Amo Type Clinical Study Protocol
Publication Title Acta Medica Okayama
Published Date 2021-12
Volume volume75
Issue issue6
Publisher Okayama University Medical School
Start Page 763
End Page 766
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34955548
Web of Science KeyUT 000735319800006
NAID 120007180272
JaLCDOI 10.18926/AMO/62810
FullText URL 75_6_705.pdf
Author Iwata, Takehiro| Maruyama, Yuki| Kawada, Tatsushi| Sadahira, Takuya| Katayama, Satoshi| Takamoto, Atsushi| Sako, Tomoko| Wada, Koichiro| Edamura, Kohei| Kobayashi, Yasuyuki| Araki, Motoo| Watanabe, Masami| Watanabe, Toyohiko| Nasu, Yasutomo|
Abstract Optimal neoadjuvant hormone therapy (NHT) for reducing prostate cancer (PC) patients’ prostate volume pre-brachytherapy is controversial. We evaluated the differential impact of neoadjuvant gonadotropin-releasing hormone (GnRH) antagonist versus agonist on post-brachytherapy testosterone recovery in 112 patients treated pre-brachytherapy with NHT (GnRH antagonist, n=32; GnRH agonists, n=80) (Jan. 2007-June 2019). We assessed the effects of patient characteristics and a GnRH analogue on testosterone recovery with logistic regression and a propensity score analysis (PSA). There was no significant difference in the rate of testosterone recovery to normal levels (> 300 ng/dL) between the GnRH antagonist and agonists (p=0.07). The GnRH agonists induced a significantly more rapid testosterone recovery rate at 3 months post-brachytherapy versus the GnRH antagonist (p<0.0001); there was no difference in testosterone recovery at 12 months between the GnRH antagonist/agonists (p=0.8). In the multivariate analysis, no actor was associated with testosterone recovery. In the PSA, older age and higher body mass index (BMI) were significantly associated with longer testosterone recovery. Post-brachytherapy testosterone recovery was quicker with the neoadjuvant GnRH agonists than the antagonist, and the testosterone recovery rate was significantly associated with older age and higher BMI. Long-term follow-ups are needed to determine any differential effects of GnRH analogues on the quality of life of brachytherapy-treated PC patients.
Keywords testosterone recovery GnRH antagonist GnRH agonist brachytherapy prostate cancer
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-12
Volume volume75
Issue issue6
Publisher Okayama University Medical School
Start Page 705
End Page 711
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34955538
Web of Science KeyUT 000735297900006
NAID 120007180282
FullText URL fulltext.pdf
Author Wada, Koichiro| Araki, Motoo| Tanimoto, Ryuta| Sadahira, Takuya| Watari, Shogo| Maruyama, Yuki| Mitsui, Yosuke| Nakajima, Hirochika| Acosta, Herik| Katayama, Satoshi| Iwata, Takehiro| Nishimura, Shingo| Takamoto, Atsushi| Sako, Tomoko| Edamura, Kohei| Kobayashi, Yasuyuki| Watanabe, Masami| Watanabe, Toyohiko| Nasu, Yasutomo|
Keywords Photodynamic diagnosis 5-Aminolevulinic acid ALA-PDD Upper urinary tract urothelial carcinoma VISERA ELITE video system
Published Date 2021-03-25
Publication Title BMC urology
Volume volume21
Issue issue1
Publisher BMC
Start Page 45
ISSN 1471-2490
NCID AA12035460
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2021.
File Version publisher
PubMed ID 33765999
NAID 120007008530
DOI 10.1186/s12894-021-00819-2
Web of Science KeyUT 000632906900001
Related Url isVersionOf https://doi.org/10.1186/s12894-021-00819-2
FullText URL fulltext.pdf
Author Janisch, Florian| Abufaraj, Mohammad| Fajkovic, Harun| Kimura, Shoji| Iwata, Takehiro| Nyirady, Peter| Rink, Michael| Shariat, Shahrokh F.|
Keywords Disease management Primary urethral carcinoma Prognosis Therapy Treatment
Published Date 2019-07-13
Publication Title European Urology Focus
Volume volume5
Issue issue5
Publisher Elsevier
Start Page 722
End Page 734
ISSN 24054569
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2019 European Association of Urology. Published by Elsevier B.V.
File Version publisher
PubMed ID 31307949
DOI 10.1016/j.euf.2019.07.001
Web of Science KeyUT 000490140000008
Related Url isVersionOf https://doi.org/10.1016/j.euf.2019.07.001